Newsletters

  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
All
  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
R&D InsightSummaries

Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia

Dear All (wonkish note alert — refresh your coffee before proceeding — with thanks to Kevin Outterson for co-authoring this ...
Read More >
Can you help?R&D Insight

Tender call: Global AMR R&D Hub seeks analyses of the market potential of four types of AMR products

Dear All, The G20-sponsored Global AMR R&D Hub (https://globalamrhub.org/) has recently published a call requesting proposals to estimate the market ...
Read More >
Can you help?R&D Insight

Virtual collaborations: JPIAMR’s Virtual Research Initiative; Global AMR Hub’s Dashboard

Dear All, If there is a silver lining to the dark cloud of COVID-19, it’s that we’re all becoming very ...
Read More >
R&D InsightSomething Different

From an IV arsenical to PO fexinidazole for Sleeping Sickness: A doctor’s dream

Dear All, As those of us who have had the privilege of standing at the bedside and delivering care know ...
Read More >
R&D Insight

Timely guidelines, regularly updated: COVID-19, C. difficile, and beyond

Dear All, During the 18-19 Nov 2019 FDA-IDSA-NIAID-Pew workshop on ways to enhance antibacterial research (link), we spent some time ...
Read More >
Can you help?R&D Insight

WHO 2020 preclinical antibacterial pipeline data call

Dear All:  As you will hopefully recall from November 2019, Theuretzbacher et al. published a review of the preclinical pipeline ...
Read More >
R&D InsightSomething Different

Movies to discover antibiotics by!

Dear All, Well, I think we can all agree that being grounded and shut away by COVID-19 is not exactly ...
Read More >
MeetingsR&D Insight

COVID-19 and bacterial infections / New webinars and meeting updates

Dear All: Three brief items for you today.  First up: Perhaps like many of you, I’ve been wondering whether or ...
Read More >
FDAGovernment Action

COVID-19 R&D support: US (FDA, BARDA, NIAID), Europe (EMA, EC), and globally (BioCentury resource hub)

Dear All, And now for a change from our usually scheduled content! As you might expect, major agencies in the ...
Read More >
Push/PullR&D Insight

Pull incentives for antibiotics: How much and why? — A review of STEDI and related literature

Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), The recent discussions of the NICE/NHS England pilot ...
Read More >
Government ActionR&D Insight

UK Antibiotic Subscription Pilot: Post-webinar FAQ document

Dear All, Kevin Outterson and I recently shared our analysis of the NICE/NHS England pilot of an antibiotic procurement subscription ...
Read More >
JobsWHO

WHO consultancy: Create online e-learning on antimicrobial stewardship

Dear All, WHO today published a Request for Proposals (RFP) for a consultant to develop an online e-learning course on ...
Read More >
R&D Insight

COVID-19 Insights from Carr, Gottlieb, McClellan / Global AMR R&D Hub Dynamic Dashboard

Dear All, Three things to share this afternoon. First, Alan Carr has published a newsletter (link) reporting the results from ...
Read More >
Government ActionPush/Pull

UK Antibiotic Subscription Pilot implies Pull Incentive of up to $4b across the G20

Note that there is a follow-up newsletter that covers a post-webinar FAQ. After reading this newsletter as introduction, please go ...
Read More >
Can you help?R&D Insight

Let’s help Alan Carr do a COVID-19 point insight survey

Dear All, I promise that the next email will be all about the 25 Mar 2020 NHS England webinar on ...
Read More >
R&D Insight

Send a note to your congressman/woman today!

Dear All, If you are a US citizen, you have an opportunity right now (as in today/tomorrow) to push for ...
Read More >
R&D Insight

Tetraphase sold for $14m … and $600m goes up in smoke!

Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter): Wonkish and long note alert … top-up your coffee ...
Read More >
R&D Insight

Sweden to test an access-focused model for new antibiotics: Contracting for Availability

Dear All: Sweden has been a steady supporter of work on incentives for antibiotics for over a decade – as ...
Read More >
Government ActionR&D Insight

NHS England antibiotic procurement pilot project: Update webinar on 25 Mar 2020

Dear All, This email was just today received from the team leading the NHS England antibiotic procurement project (go here ...
Read More >
JobsWHO

WHO R&D-focused consultancy: Data coordinator for next WHO pipeline review

Dear All, As you know, WHO has been driving a series of clinical and preclinical pipeline reviews (go here for ...
Read More >
Scroll to Top